Chang et al., 2020 - Google Patents
HLA‐B27 association of autoimmune encephalitis induced by PD‐L1 inhibitorChang et al., 2020
View PDF- Document ID
- 6265116580405767543
- Author
- Chang H
- Shin Y
- Keam B
- Kim M
- Im S
- Lee S
- Publication year
- Publication venue
- Annals of Clinical and Translational Neurology
External Links
Snippet
Objective While immune checkpoint inhibitors are increasingly used for various cancers, unpredictable immune‐related adverse events (irAEs) such as autoimmune encephalitis is life‐threatening. Here, we report an association between human leukocyte antigen (HLA) …
- 208000003579 Hashimoto's encephalitis 0 title abstract description 17
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
- G06F19/18—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for functional genomics or proteomics, e.g. genotype-phenotype associations, linkage disequilibrium, population genetics, binding site identification, mutagenesis, genotyping or genome annotation, protein-protein interactions or protein-nucleic acid interactions
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Chang et al. | HLA‐B27 association of autoimmune encephalitis induced by PD‐L1 inhibitor | |
| Jing et al. | Association of antibiotic treatment with immune-related adverse events in patients with cancer receiving immunotherapy | |
| Amstutz et al. | Recommendations for HLA‐B* 15: 02 and HLA‐A* 31: 01 genetic testing to reduce the risk of carbamazepine‐induced hypersensitivity reactions | |
| Boige et al. | DPYD genotyping to predict adverse events following treatment with fluorouracil-based adjuvant chemotherapy in patients with stage III colon cancer: a secondary analysis of the PETACC-8 randomized clinical trial | |
| Di Meglio et al. | Dynamics of long-term patient-reported quality of life and health behaviors after adjuvant breast cancer chemotherapy | |
| Walker et al. | Personalized medicine approaches in epilepsy | |
| Lin et al. | A patch testing and cross‐sensitivity study of carbamazepine‐induced severe cutaneous adverse drug reactions | |
| Hewett et al. | Randomized study of adjunctive belimumab in participants with generalized myasthenia gravis | |
| Leckband et al. | Clinical Pharmacogenetics Implementation Consortium guidelines for HLA‐B genotype and carbamazepine dosing | |
| Friedman et al. | Treatment of the immune-related adverse effects of immune checkpoint inhibitors: a review | |
| Kolb et al. | Neuromuscular complications of immune checkpoint inhibitor therapy | |
| Watters et al. | Genome-wide discovery of loci influencing chemotherapy cytotoxicity | |
| Moon et al. | The HLA‐A* 2402/C w* 0102 haplotype is associated with lamotrigine‐induced maculopapular eruption in the K orean population | |
| Johnson et al. | Genetic factors underlying the risk of thalidomide-related neuropathy in patients with multiple myeloma | |
| Trivedi et al. | Alterations in DNA methylation status associated with gulf war illness | |
| Haider et al. | Ustekinumab dose escalation improves clinical responses in refractory Crohn’s disease | |
| Liu et al. | Risk of extrathymic cancer in patients with myasthenia gravis in Taiwan: a nationwide population‐based study | |
| Gordon-Lipkin et al. | An update on multiple sclerosis in children: diagnosis, therapies, and prospects for the future | |
| Mahmoudpour et al. | Chemotherapy-induced peripheral neuropathy: evidence from genome-wide association studies and replication within multiple myeloma patients | |
| Szoeke et al. | Multidrug‐resistant genotype (ABCB1) and seizure recurrence in newly treated epilepsy: data from international pharmacogenetic cohorts | |
| Petersen et al. | Altered immune phenotype and DNA methylation in panic disorder | |
| Özkan et al. | Geriatric predictors of response and adverse events in older patients with cancer treated with immune checkpoint inhibitors: a systematic review | |
| Asadi‐Pooya et al. | Potential role of FKBP5 single‐nucleotide polymorphisms in functional seizures | |
| Wong et al. | HLA‐B* 15: 11 status and carbamazepine‐induced severe cutaneous adverse drug reactions in HLA‐B* 15: 02 negative Chinese | |
| Mortazavi et al. | Association between human leukocyte antigens and cutaneous adverse drug reactions to antiepileptics and antibiotics in the Iranian population |